Structure-guided engineering of type I-F CASTs for targeted gene insertion in human cells
- PMID: 40849322
- PMCID: PMC12375015
- DOI: 10.1038/s41467-025-63164-0
Structure-guided engineering of type I-F CASTs for targeted gene insertion in human cells
Abstract
Conventional genome editing tools rely on DNA double-strand breaks (DSBs) and host recombination proteins to achieve large insertions, resulting in heterogeneous mixtures of undesirable outcomes. We recently leveraged a type I-F CRISPR-associated transposase, PseCAST, for DSB-free DNA integration in human cells, albeit at low efficiencies; multiple lines of evidence suggest DNA binding may be a bottleneck for higher efficiencies. Here we report structural determinants of DNA recognition by the PseCAST QCascade complex using single-particle cryogenic electron microscopy (cryoEM), revealing subtype-specific interactions and RNA-DNA heteroduplex features. By combining structural data, library screens, and rationally engineered mutants, we uncover variants with increased integration efficiencies and modified PAM stringencies. We further leverage transpososome structural predictions to build hybrid CASTs that combine orthogonal DNA binding and integration modules. Our work provides unique structural insights into type I-F CASTs and showcases diverse strategies to investigate and engineer RNA-guided transposase architectures for human genome editing applications.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: Columbia University has filed a patent application related to this work. G.D.L., A.R.L., D.J.Z., and S.H.S. are inventors on other patents and patent applications related to CRISPR–Cas systems and uses thereof (application numbers US20240279629, US20250163410, WO2020181264, WO2022261122, WO2022266492, WO2023245010, WO2024124048, WO2025029727, WO2025085782, WO2025085787). S.H.S. is a co-founder of and scientific advisor to Dahlia Biosciences, a scientific advisor to Prime Medicine and CrisprBits and an equity holder in Dahlia Biosciences and CrisprBits. The remaining authors declare no competing interests.
Figures





Update of
-
Structure-guided engineering of type I-F CASTs for targeted gene insertion in human cells.bioRxiv [Preprint]. 2024 Sep 19:2024.09.19.613948. doi: 10.1101/2024.09.19.613948. bioRxiv. 2024. Update in: Nat Commun. 2025 Aug 23;16(1):7891. doi: 10.1038/s41467-025-63164-0. PMID: 39345383 Free PMC article. Updated. Preprint.
Similar articles
-
Structure-guided engineering of type I-F CASTs for targeted gene insertion in human cells.bioRxiv [Preprint]. 2024 Sep 19:2024.09.19.613948. doi: 10.1101/2024.09.19.613948. bioRxiv. 2024. Update in: Nat Commun. 2025 Aug 23;16(1):7891. doi: 10.1038/s41467-025-63164-0. PMID: 39345383 Free PMC article. Updated. Preprint.
-
Phage-based delivery of CRISPR-associated transposases for targeted bacterial editing.Proc Natl Acad Sci U S A. 2025 Jul 29;122(30):e2504853122. doi: 10.1073/pnas.2504853122. Epub 2025 Jul 25. Proc Natl Acad Sci U S A. 2025. PMID: 40711918 Free PMC article.
-
Mechanisms and engineering of a miniature type V-N CRISPR-Cas12 effector enzyme.Nat Commun. 2025 Jul 1;16(1):5667. doi: 10.1038/s41467-025-61290-3. Nat Commun. 2025. PMID: 40595633 Free PMC article.
-
Bacterial genome engineering using CRISPR-associated transposases.Nat Protoc. 2024 Mar;19(3):752-790. doi: 10.1038/s41596-023-00927-3. Epub 2024 Jan 12. Nat Protoc. 2024. PMID: 38216671 Free PMC article. Review.
-
TIGR-Tas and the Expanding Universe of RNA-Guided Genome Editing Systems: A New Era Beyond CRISPR-Cas.Genes (Basel). 2025 Jul 28;16(8):896. doi: 10.3390/genes16080896. Genes (Basel). 2025. PMID: 40869944 Free PMC article. Review.
References
-
- Branzei, D. & Foiani, M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol.9, 297–308 (2008). - PubMed
-
- Pawelczak, K. S., Gavande, N. S., VanderVere-Carozza, P. S. & Turchi, J. J. Modulating DNA repair pathways to improve precision genome engineering. ACS Chem. Biol.13, 389–396 (2018). - PubMed
-
- Zuccaro, M. V. et al. Allele-specific chromosome removal after Cas9 cleavage in human embryos. Cell183, 1–15 (2020). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous